Dr. Dylan Burger
Ottawa Hospital Research Institute
Supervisor: Dr. Rhian Touyz
KRESCENT FELLOWSHIP 2009-2012
Dylan Burger will undertake his Post-Doctoral Fellowship under the mentorship of Dr. Rhian Touyz at the Kidney Research Centre, Ottawa Hospital Research Institute where he will study how microparticles may contribute to hypertension. Microparticles are tiny pieces of cells that are released from dying cells in the body. Recently it has been found that the levels of microparticles in the blood are increased in many diseases, including hypertension. These tiny pieces of cells appear to be able to exert significant effects on the body such as promoting the clotting of blood. Understanding the proteins carried by microparticles and the signaling that microparticles activate in living cells can potentially help develop new drug treatments for hypertension, as well as other disease processes such as heart and kidney failure.
The KRESCENT Program is a Strategic Training Program developed and supported by:
With additional generous support from:
AMGEN Baxter Corporation Merck-Frosst Canada Ltd. Ortho Biotech RocheShire BioChem Inc.